Hiperlipidemi ve Kanıta Dayalı Tedavi Bakım Uygulamaları

Thobani A, Jacobson TA. Dyslipidemia in patients with kidney disease. Cardiology clinics. 2021;39(3):353-63. doi: 10.1016/j.ccl.2021.04.008

Rosenstein K, Tannock LR. Dyslipidemia in chronic kidney disease. 2022. In: Comprehensive Online Endocrinology Book [Internet]. Massachusetts, Amerika Birleşik Devletleri Endotext. Available from: 20/04/2024 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK305899/ adresinden ulaşılmıştır.

Rehman S, Kumar S, Mehboob F, Rehman F, Ali SH, Raja K. Impact of Duration of Hemodialysis on Lipid Profile in End Stage Renal Disease Patients Receiving Hemodialysis. The Professional Medical Journal. 2020;27(6):1230-6. doi: 10.29309/TPMJ/2020.27.06.4188

Fatima A, Anwar S, Ahmad S, Usman HT, Anwar Z. Frequency of Dyslipidemia among End-Stage Renal Disease Patients on Thrice Weekly Maintenance Hemodialysis. Pakistan Journal of Medical & Health Sciences. 2022;16(2):350-2. doi: 10.53350/pjmhs22162350

Malik SI, Khan R, Imran A, Akram M, Maqbool S, Habib R. Frequency of dyslipidemia in patients undergoing maintenance hemodialysis at Bahawal Victoria Hospital, Bahawalpur. The Professional Medical Journal. 2020;27(9):1829-33. doi: 10.29309/TPMJ/2020.27.09.3975

Hasan YK, Alsultan M, Anan MT, Hassn Q, Basha K. The prevalence of dyslipidemia in patients on hemodialysis: a cross-sectional study from Syria. Annals of Medicine and Surgery. 2023;85(8):3838-44. doi: 10.1097/MS9.0000000000000931

Reule S, Ishani A, Goldsmith D. Dyslipidemia and Chronic Kidney Disease. In: Kimmel PL, Rosenberg ME, editors. Chronic Renal Disease 2. Baskı ed. Massachusetts, Amerika Birleşik Devletleri: Academic Press; 2020. p. 1093-101.

Allard-Ratick MP, Kindya BR, Khambhati J, Engels MC, Sandesara PB, Rosenson RS, Sperling LS. HDL: Fact, fiction, or function? HDL cholesterol and cardiovascular risk. European journal of preventive cardiology. 2021;28(2):166-73. doi: 10.1177/2047487319848214

Kochan Z, Szupryczynska N, Malgorzewicz S, Karbowska J. Dietary Lipids and Dyslipidemia in Chronic Kidney Disease. Nutrients. 2021;13(9):1-18. doi: 10.3390/nu13093138

Chu M, Wang AY, Chan IH, Chui SH, Lam CW. Serum small-dense LDL abnormalities in chronic renal disease patients. British Journal of Biomedical Science. 2012;69(3):99-102. doi: 10.1080/09674845.2012.12069133

Qiao Y-N, Zou Y-L, Guo S-D. Low-density lipoprotein particles in atherosclerosis. Frontiers in Physiology. 2022;13. doi: 10.3389/fphys.2022.931931

Vekic J, Zeljkovic A, Cicero AFG, Janez A, Stoian AP, Sonmez A, Rizzo M. Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL. Medicina. 2022;58(2):1-12. doi: 10.3390/medicina58020299

Reis A, Rudnitskaya A, Chariyavilaskul P, Dhaun N, Melville V, Goddard J, et al. Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease. J Lipid Res. 2015;56(2):413-22. doi: 10.1194/jlr.M055624

Suh SH, Kim SW. Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview. Diabetes Metab J. 2023;47(5):612-29. doi: 10.4093/dmj.2023.0067

Noels H, Lehrke M, Vanholder R, Jankowski J. Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations. Nature Reviews Nephrology. 2021;17(8):528-42. doi: 10.1038/s41581-021-00423-5

Barbagelata L, Masson W, Corral P, Lavalle-Cobo A, Nogueira JP, Rosa Diez G. Relationship between lipoprotein(a) levels, cardiovascular outcomes and death in patients with chronic kidney disease: a systematic review of prospective studies. Journal of Nephrology. 2023;36(6):1549-59. doi: 10.1007/s40620-023-01590-3

Yuan Y, Chen W, Luo L, Xu C. Dyslipidemia: Causes, symptoms and treatment. International Journal of Trend in Scientific Research and Development. 2021;5(2):1013-6.

Feingold KR, Grunfeld C. Diabetes and dyslipidemia. In: Johnstone M, Veves A, editors. Diabetes and Cardiovascular Disease. Berlin, Almanya: Springer; 2023. p. 425-72.

Purva A, Sharma K, Khan MS. A review on dyslipidemia: types, risk factors and management. Asian Journal of Pharmaceutical Research and Development. 2020;8(2):96-8. doi: 10.22270/ajprd.v8i2.682

Simha V. Drug-Induced Dyslipidemia. In: Garg A, editor. Dyslipidemias: Pathophysiology, Evaluation and Management. New Jersey, Amerika Birleşik Devletleri: Humana Press; 2015. p. 267-86.

Habte ML, Beyene AE, Feyisa OT. Dyslipidemia and Endocrine Disorders In: Aronow WS, editor. Management of Dyslipidemia. Londra, İngiltere: IntechOpen 2021. p. 51-60.

Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. Journal of the American College of Cardiology. 2020;75(17):2122-35. doi: 10.1016/j.jacc.2020.02.059

Akdemir N, Canlı Özer Z. Kardiyovasküler Sistem Hastalıkları ve Hemşirelik Bakımı. In: Akdemir N, Birol L, editors. İç Hastalıkları ve Hemşirelik Bakımı. Güncellenmiş 5. Baskı ed. Ankara, Türkiye: Akademisyen Kitabevi 2020. p. 505-620.

Shao C, Wang J, Tian J, Tang Y-d. Coronary artery disease: from mechanism to clinical practice. In: Wang M, editor. Coronary Artery Disease: Therapeutics and Drug Discovery. Singapur: Springer; 2020. p. 1-36.

Abramson BL, Al-Omran M, Anand SS, Albalawi Z, Coutinho T, de Mestral C, et al. Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease. Canadian Journal of Cardiology. 2022;38(5):560-87. doi: 10.1016/j.cjca.2022.02.029

Wanner C, Tonelli M. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney international. 2014;85(6):1303-9. doi: 10.1038/ki.2014.31

Lipsy RJ. The National Cholesterol Education Program Adult Treatment Panel III guidelines. Journal of managed care pharmacy: JMCP. 2003;9(Supplement 1 ):2-5. doi: 10.18553/jmcp.2003.9.s1.2

Goff Jr DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 supplement 2):49-73. doi: 10.1161/01.cir.0000437741.48606.98

Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47. doi: 10.1161/01.CIR.97.18.1837

Saglimbene V, Palmer SC, Strippoli GFM. Management of Dyslipidemia in Long-Term Dialysis Patients. In: Nissenson AR, Fine RN, Mehrotra R, Zaritsky J, editors. Handbook of Dialysis Therapy (Sixth Edition). New Delhi, Hindistan Elsevier; 2023. p. 430-3.

Satny M, Hubacek JA, Vrablik M. Statins and inflammation. Current atherosclerosis reports. 2021;23:1-8. doi: 10.1007/s11883-021-00977-6

Hirota T, Fujita Y, Ieiri I. An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins. Expert Opinion on Drug Metabolism & Toxicology. 2020;16(9):809-22. doi: 10.1080/17425255.2020.1801634

Roux C, Verollet K, Prouvot J, Prelipcean C, Pambrun E, Moranne O. Choosing the right chronic medication for hemodialysis patients. A short ABC for the dialysis nephrologist. Journal of Nephrology. 2023;36(2):521-36. doi: 10.1007/s40620-022-01477-9

Jung J, Bae GH, Kang M, Kim SW, Lee DH. Statins and all‐cause mortality in patients undergoing hemodialysis. Journal of the American Heart Association. 2020;9(5):1-27. doi: 10.1161/JAHA.119.014840

Goto H, Iseri K, Hida N. Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients. Nephrology Dialysis Transplantation. 2023;0(0):1-7. doi: 10.1093/ndt/gfad248

Kirkpatrick CF, Sikand G, Petersen KS, Anderson CAM, Aspry KE, Bolick JP, et al. Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association. Journal of Clinical Lipidology. 2023;17(4):428-51. doi: 10.1016/j.jacl.2023.05.099

Demeter SH. The Latest Strategies in Dyslipidemia Diagnosis and Management Kaliforniya, Amerika Preventive Cardiovascular Nurses Association 2023 [(20/04/2024 tarihinde https://pcna.net/the-latest-strategies-in-dyslipidemia-diagnosis-and-management/ adresinden ulaşılmıştır. ).

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European heart journal. 2020;41(1):111-88. doi: 10.1093/eurheartj/ehz455

Ferrari F, Helal L, Dipp T, Soares D, Soldatelli Â, Mills AL, et al. Intradialytic training in patients with end-stage renal disease: a systematic review and meta-analysis of randomized clinical trials assessing the effects of five different training interventions. Journal of Nephrology. 2020;33(2):251-66. doi: 10.1007/s40620-019-00687-y

Pu J, Jiang Z, Wu W, Li L, Zhang L, Li Y, et al. Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis. BMJ open. 2019;9(1):1-12. doi: 10.1136/bmjopen-2017-020633

Li L, Ma X, Xie C, Li Y. Resistance exercise interventions for sarcopenia and nutritional status of maintenance hemodialysis patients: a meta-analysis. PeerJ. 2024;12:1-21. doi: 10.7717/peerj.16909

Frih B, Jaafar H, Mkacher W, Ben Salah Z, Hammami M, Frih A. The Effect of Interdialytic Combined Resistance and Aerobic Exercise Training on Health Related Outcomes in Chronic Hemodialysis Patients: The Tunisian Randomized Controlled Study. Frontiers in Physiology. 2017;8:1-11. doi: 10.3389%2Ffphys.2017.00288

MowafyEmam Z, Swar SA, Elthakaby AH, Mohamed H. Impact of Aerobic Versus Resisted Exercises on Lipid Profiles in Patients Undergoing Hemodialysis. International Journal of Recent Advances in Multidisciplinary Research. 2020;7(3):5626-30.

Bogataj Š, Pajek J, Buturović Ponikvar J, Pajek M. Functional training added to intradialytic cycling lowers low-density lipoprotein cholesterol and improves dialysis adequacy: a randomized controlled trial. BMC Nephrology. 2020;21(1):352. doi: 10.1186/s12882-020-02021-2

Cheng Y-J, Zhao X-J, Zeng W, Xu M-C, Ma Y-C, Wang M. Effect of intradialytic exercise on physical performance and cardiovascular risk factors in patients receiving maintenance hemodialysis: A pilot and feasibility study. Blood Purification. 2020;49(4):409-18. doi: 10.1159/000504955

Lin C-H, Hsu Y-J, Hsu P-H, Lee Y-L, Lin C-H, Lee M-S, Chiang S-L. Effects of Intradialytic Exercise on Dialytic Parameters, Health-Related Quality of Life, and Depression Status in Hemodialysis Patients: A Randomized Controlled Trial. International Journal of Environmental Research and Public Health. 2021;18(17):1-16. doi: 10.3390/ijerph18179205

Rosa TS, Corrêa HL, Deus LA, Stone W, Reis AL, Gadelha AB, et al. Effects of dynamic and isometric resistance training protocols on metabolic profile in hemodialysis patients: a randomized controlled trial. Applied Physiology, Nutrition, and Metabolism. 2021;46(9):1029-37. doi: 10.1139/apnm-2020-0900

Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero J-J, Chan W, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. American Journal of Kidney Diseases. 2020;76(3):1-107. doi: 10.1053/j.ajkd.2020.05.006

Guasch‐Ferré M, Willett W. The Mediterranean diet and health: A comprehensive overview. Journal of internal medicine. 2021;290(3):549-66. doi: 10.1111/joim.13333

Finicelli M, Di Salle A, Galderisi U, Peluso G. The Mediterranean diet: an update of the clinical trials. Nutrients. 2022;14(14):1-21. doi: 10.3390/nu14142956

van Westing AC, Küpers LK, Geleijnse JM. Diet and Kidney Function: a Literature Review. Current Hypertension Reports. 2020;22(2):1-9. doi: 10.1007/s11906-020-1020-1

Rysz J, Franczyk B, Ciałkowska-Rysz A, Gluba-Brzózka A. The Effect of Diet on the Survival of Patients with Chronic Kidney Disease. Nutrients. 2017;9(5):1-17. doi: 10.3390/nu9050495

Suri S, Kumar V, Kumar S, Goyal A, Tanwar B, Kaur J, Kaur J. DASH dietary pattern: a treatment for non-communicable diseases. Current hypertension reviews. 2020;16(2):108-14. doi: 10.2174/1573402115666191007144608

Said MS, El Sayed IT, Ibrahim EE, Khafagy GM. Effect of DASH Diet Versus Healthy Dietary Advice on the Estimated Atherosclerotic Cardiovascular Disease Risk. Journal of Primary Care & Community Health. 2021;12:1-8. doi: 10.1177/2150132720980952

Wilson PW, Polonsky TS, Miedema MD, Khera A, Kosinski AS, Kuvin JT. Systematic review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):1144-61. doi: 10.1161/CIR.0000000000000626

Stubbs RJ. Impact of carbohydrates, fat and energy density on energy intake. Nature Medicine. 2021;27(2):200-1. doi: 10.1038/s41591-021-01241-9

Kapoor B, Kapoor D, Gautam S, Singh R, Bhardwaj S. Dietary polyunsaturated fatty acids (PUFAs): Uses and potential health benefits. Current nutrition reports. 2021;10:232-42. doi: 10.1007/s13668-021-00363-3

Mirfatahi M, Tabibi H, Nasrollahi A, Hedayati M. Effects of Flaxseed Oil on Serum Lipids and Lipoproteins in Hemodialysis Patients: a Randomized Controlled Trial. Iran J Kidney Dis. 2016;10(6):405-12.

Orsavova J, Misurcova L, Ambrozova JV, Vicha R, Mlcek J. Fatty Acids Composition of Vegetable Oils and Its Contribution to Dietary Energy Intake and Dependence of Cardiovascular Mortality on Dietary Intake of Fatty Acids. International Journal of Molecular Sciences. 2015;16(6):12871-90. doi: 10.3390/ijms160612871

Neelakantan N, Seah JYH, van Dam RM. The effect of coconut oil consumption on cardiovascular risk factors: a systematic review and meta-analysis of clinical trials. Circulation. 2020;141(10):803-14. doi: 10.1161/CIRCULATIONAHA.119.043052

Bhandari SD, Delmonte P, Honigfort M, Yan W, Dionisi F, Fleith M, et al. Regulatory changes affecting the production and use of fats and oils: Focus on partially hydrogenated oils. Journal of the American Oil Chemists' Society. 2020;97(8):797-815. doi: 10.1002/aocs.12366

Apetrii M, Timofte D, Voroneanu L, Covic A. Nutrition in chronic kidney disease—the role of proteins and specific diets. Nutrients. 2021;13(3):1-15. doi: 10.3390/nu13030956

Puglisi MJ, Fernandez ML. The health benefits of egg protein. Nutrients. 2022;14(14):1-14. doi: 10.3390/nu14142904

Azmandian J, Shamspour N, Alinaghi Langari T, Talaei Khales Soflaei B, Alinaghi Langari A, Ahmadipour H, et al. The effect of egg white diet on phosphorus control in dialysis patients. Hemodialysis International. 2022;26(4):555-61. doi: 10.1111/hdi.13028

Oliver L, Dietrich T, Marañón I, Villarán MC, Barrio RJ. Producing omega-3 polyunsaturated fatty acids: A review of sustainable sources and future trends for the EPA and DHA market. Resources. 2020;9(12):1-15. doi: 10.3390/resources9120148

Tsoupras A, Brummell C, Kealy C, Vitkaitis K, Redfern S, Zabetakis I. Cardio-protective properties and health benefits of fish lipid bioactives; the effects of thermal processing. Marine Drugs. 2022;20(3):1-46. doi: 10.3390/md20030187

He L, Li M-s, Lin M, Zhao T-y, Gao P. Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials. European Journal of Clinical Pharmacology. 2016;72(2):129-39. doi: 10.1007/s00228-015-1976-y

Huang H, Song L, Zhang H, Zhang H, Zhang J, Zhao W. Influence of L-Carnitine Supplementation on Serum Lipid Profile in Hemodialysis Patients: A Systematic Review and Meta-Analysis. Kidney and Blood Pressure Research. 2014;38(1):31-41. doi: 10.1159/000355751

Marx W, Kelly J, Marshall S, Nakos S, Campbell K, Itsiopoulos C. The Effect of Polyphenol-Rich Interventions on Cardiovascular Risk Factors in Haemodialysis: A Systematic Review and Meta-Analysis. Nutrients. 2017;9(12):1-24. doi: 10.3390/nu9121345

Chen C, Wang J, Li J, Zhang W, Ou S. Probiotics, prebiotics, and synbiotics for patients on dialysis: a systematic review and meta-analysis of randomized controlled trials. Journal of Renal Nutrition. 2023;33(1):126-39. doi: 10.1053/j.jrn.2022.04.001

Liu R, Jiang J, Fu Z, Liu C, Yao L, Quan H. Effects of omega-3 fatty acid intake in patients undergoing dialysis: a systematic review and meta-analysis of randomized controlled trials. Journal of the American Nutrition Association. 2022;41(7):697-712. doi: 10.1080/07315724.2021.1953416

Jiang Z, Tang Y, Yang L, Mi X, Qin W. Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease: a systematic review and meta-analysis. International Urology and Nephrology. 2018;50(4):687-94. doi: 10.1007/s11255-017-1713-9

Wang L-J, Wang M-Q, Hu R, Yang Y, Huang Y-S, Xian S-X, Lu L. Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials. BioMed Research International. 2017;2017:1-12. doi: 10.1155/2017/1024769